No quick fix seen for Novartis's troubled Alcon unit

ZURICH (Reuters) - Introduced a decade ago, glaucoma drug Travatan Z has been a powerful driver behind the success of Novartis's Alcon eye care business, its second biggest division behind the main pharmaceuticals business.

http://ift.tt/1SdjUUZ

from Reuters: Health News
via animenewspro